Cytox Release: Role Of mTOR Pathway As A Marker Of Risk In Alzheimer's Disease To Be Presented At AAIC 2014
7/14/2014 10:25:00 AM
Cytox, a leading developer of assays for risk assessment and prediction of dementia, announced the timing of a presentation discussing the development of a novel proprietary blood-based assay for the assessment of risk of cognitive decline.
Help employers find you! Check out all the jobs and post your resume.
comments powered by